Clinical trial
Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis
NCT02792946 is registered in ClinicalTrials.gov with Hyundai Pharmaceutical Co., LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis
- Lead sponsor
- Hyundai Pharmaceutical Co., LTD.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- January 31, 2016
- Enrollment
- 244 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute bronchitis